Clinical Trials Logo
  1. Home
  2. Healthcare Associated Infection
  3. NCT03189043

Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections

Healthcare Associated Infection Clinical Trial

Official title:
Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections

Clinical Trial Summary

This is a controlled open label efficacy study of Aionx antimicrobial surface for the prevention of healthcare-associated infections.

Clinical Trial Description

The study is an open label controlled efficacy trial of Aionx patented antimicrobial surface for the prevention of healthcare-associated infections (HAIs). It will take place at Penn State Hershey. Half of the single occupancy rooms of the 5th and 7th floor will be assigned to contain the antimicrobial surface at five locations: bed rails, overbed table, door handles, counter, and arm rests of bedside chair. The remaining rooms will serve as controls. Data on HAIs will be gathered for all the patients admitted to the rooms during the duration of the study. After 45 days the rooms will be flipped so that test rooms become controls and control rooms become test rooms. The duration of the study will be for a minimum of 90 days. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03189043
Study type Interventional
Source Aionx, Inc.
Contact Jose A Stoute, M.D.
Phone 3017583689
Email jstoute@psu.edu
Status Not yet recruiting
Phase Phase 2
Start date July 1, 2017
Completion date October 1, 2017
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04976829 - Evaluating Antibiotic Stewardship Assisted by Computer in the University Hospital of Nancy (MACABAO)
Recruiting NCT05589727 - Application of Ventilator-Associated Events (VAE) in Ventilator-Associated Pneumonia (VAP) Notified in Brazil
Completed NCT04873557 - Copper Use as Protection Against Antimicrobial Resistance in the ICU N/A
Completed NCT03843021 - Ventricular Assist Device (VAD) Infection Prevention Survey
Recruiting NCT04579094 - Prevalence and Risk Factors for the Carriage of Bacteria and Clostridioid in Elderly Dependent Persons
Recruiting NCT04192435 - Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery Phase 4
Recruiting NCT06216080 - Dynamic Full-Field Optical Coherence Tomography for Structural and Microbiological Characterization of Central Venous Catheter-deposited Biofilm in Critically Ill Patients
Enrolling by invitation NCT03924934 - Community-associated Highly-Resistant Enterobacterales
Recruiting NCT06379139 - Dynamic Full-field Optical Coherence Tomography for Structural and Microbiological Characterization of Endotracheal Tube Biofilm in Critically Ill Patients
Recruiting NCT06155747 - Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
Completed NCT03349268 - Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection N/A
Completed NCT04053257 - Effect of Video Camera Monitoring Feedback on Hand Hygiene Compliance and Infections in NICU N/A
Completed NCT05797818 - Red Light Photobiomodulation and Topical Disinfectants Phase 1/Phase 2
Terminated NCT03361085 - Modular Prevention Bundle for Non-ventilator-associated Hospital-acquired Pneumonia (nvHAP) N/A
Completed NCT04770597 - Monitors to Improve Indoor Carbon Dioxide (CO2) Concentrations in the Hospital N/A
Recruiting NCT05612672 - Evaluation of GeoHAI Implementation N/A
Completed NCT02605499 - Ultra Violet-C Light Evaluation as an Adjunct to Removing Multi-Drug Resistant Organisms (UVCLEAR-MDRO) N/A
Completed NCT04676581 - Risk Benefit Ratio of Hirudotherapy: Retrospective Single-center Study of 37 Cases Over a Period of 9 Years
Recruiting NCT05979545 - EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics Phase 4
Active, not recruiting NCT04312243 - NO Prevention of COVID-19 for Healthcare Providers Phase 2